drugset / Trial / NCT06591455
A Pilot Study of Fenofibrate and Ursodeoxycholic Acid in the Treatment of Newly Diagnosed Primary Biliary Cholangitis
RandomizedParallel-groupOpen-labelTreatment
Summary
This study is a prospective, single center, randomized controlled, exploratory clinical trial aimed at evaluating the efficacy and safety of fenofibrate in newly diagnosed PBC subjects.
Timeline
- Start
- 2024-09-14
- Primary completion
- 2025-08-18
- Completion
- 2025-08-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fenofibrate | Small molecule | 200 mg | — |
| Comparator | Ursodeoxycholic Acid | Small molecule | 13 mg/kg | — |
| Comparator | Ursodeoxycholic Acid | Small molecule | 15 mg/kg | — |